Similar articles

• Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.

  La E, Muga SJ, Locniskar MF, Fischer SM. La E, et al. Mol Carcinog. 1999 Apr;24(4):276-86. Mol Carcinog. 1999. PMID: 10326864
• Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.

  Stern MC, Benavides F, LaCava M, Conti CJ. Stern MC, et al. Mol Carcinog. 2002 Sep;35(1):13-20. doi: 10.1002/mc.10067. Mol Carcinog. 2002. PMID: 12203363
• Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.

  Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL. Larcher F, et al. Cancer Res. 1996 Dec 1;56(23):5391-6. Cancer Res. 1996. PMID: 8968091
• Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.

  DiGiovanni J, Rho O, Xian W, Beltràn L. DiGiovanni J, et al. Prog Clin Biol Res. 1994;387:113-38. Prog Clin Biol Res. 1994. PMID: 7972243 Review.
• Differential gene expression during tumor promotion and progression in the mouse skin model.

  Bowden GT, Ostrowski LE, Bonham K, Krieg P. Bowden GT, et al. Basic Life Sci. 1991;57:127-40; discussion 140-1. doi: 10.1007/978-1-4684-5994-4_12. Basic Life Sci. 1991. PMID: 1667569 Review. No abstract available.